DOCSLIB.ORG

A Review of Debrisoft in the Management of a Variety of Dermatological Conditions

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Review of Debrisoft in the Management of a Variety of Dermatological Conditions Product REVIEW A review of Debrisoft in the management of a variety of dermatological conditions Debbie Lorenzelli, Alberto Barea, Clare Morris This product review examines Debrisoft utilising Monofilament Fibre Technology. Debrisoft is known for its ability to remove dry skin and for the removal debris and barriers to healing from acute and chronic wounds during a process known as wound bed preparation. Debrisoft has recently had its clinical indication extended to include dermatological conditions such as eczema and psoriasis. Lorenzelli D, Barea A, Morris C. A review of Debrisoft in the management of a variety of dermatological conditions. Dermatological Nursing 2018. 17(2): 33-38 Skin problems represent a big slice of Product focus – Debrisoft of the skin or wound bed (Figure 2) and NHS activity. Indeed, in 2006, it was Debrisoft utilises Monofilament Fibre will not damage new granulating tissue reported that in England and Wales Technology (Figure 1) in the form of or epithelial cells. around 24% of the population (12.9 a debridement pad and debridement million) seek medical advice about a device or lolly. The pad comprises of 18 Debrisoft has a unique technology skin condition each year, with the most million special monofilament fibres that and mode of action for wounds and common reasons being skin infection have angled tips to reach uneven areas skin, lifting debris, including biofilm, and eczema.1 In the UK, it is estimated that 70% of older people have a skin condition and eczema is one of the most common conditions.2 In more recent publications³ it has been suggested that 23-33% of the population have a skin problem, and in surveys3 around 54% of the UK population experience a skin condition in a given twelve month period. Skin conditions cause physical discomfort, psychological distress and generally are long-term chronic conditions. Skin diseases remain a major cause of disability worldwide.4 Debbie Lorenzelli is a Dermatology Nurse Specialist at St Helens and Knowsley Teaching Hospital NHS Trust. Alberto Barea is Lead Clinical Nurse Specialist at Plastic Surgery and Dermatology, Kingston Hospital NHS Figure 1. Figure 2. Foundation Trust. Clare Morris is Senior Monofilament Fibre TechnologyTM 18 million special monofilament fibres which have angled Clinical Services Manager, L&R Medical UK Ltd. tips to reach uneven areas of the skin or wound bedTM www.bdng.org.uk Dermatological Nursing, 2018, Vol 17, No 2 33 Product REVIEW superficial slough and exudate quickly, After examining clinical evidence, Following the products launch in binding it within the fibres (Figure 2) NICE concluded: “The likely benefits of 2011, it quickly became established for and removing barriers to healing. using the Debrisoft pad on appropriate use in acute and chronic wound care,6 wounds are that they will be fully and in the management of skin conditions It is soft and conformable and gentle debrided more quickly, with fewer nurse associated with chronic venous disease7 on patients. It is also safe and easy to visits needed, compared with other and lymphedema.8 In recent years, use and can also be used by patients for debridement methods. In addition, the Debrisoft has also been used more in the self-care. Debrisoft pad is convenient and easy to field of dermatology. use, and is well tolerated by patients”.5 How to use Debrisoft 34 Dermatological Nursing, 2018, Vol 17, No 2 www.bdng.org.uk Product REVIEW Review of the dermatology related evidence Weindorf and Dissemond10 discuss The authors concluded that whilst Flinton7 describes the use of Debrisoft the challenges of debridement of painful acknowledging limitations of the study, in varicose eczema following 3 years of chronic wounds in dermatological patients they believed that the evidence indicates unsuccessful management associated such as pyoderma gangrenous and that the use of Debrisoft on psoriasis or with high costs. Five Debrisoft treatments epidermolysis bullosa. Debrisoft proved dry, scaly skin would not cause harm and over a two week period resulted in the to be a useful, non-invasive and therefore may, in longer term testing, show benefits. wounds and varicose eczema healing at safe alternative, especially for chronic the end of the two week period (Figures wounds covered in fibrin and slough. A multicenter case series evaluating 3-5). Debrisoft was continued to prevent Debrisoft in the management of the build-up of hyperkeratosis. Girip and McLoughlin11 report in a childhood atopic eczema and psoriasis case study the management of a lady was undertaken.13 Denyer9 reports on the use of with a three year history of venous leg Debrisoft in the management of children ulcer, recurrent cellulitis and chronic The primary aim of this clinical with severe epidermolysis bullosa. eczema that was successfully managed evaluation was to investigate if Debrisoft This condition is extremely challenging, with debridement of the wound and skin would benefit the skin care regime of with wound management often being with Debrisoft in her own home. It was children suffering from atopic eczema painful and time consuming. Denyer important for this patient that a hospital and psoriasis compared with their recommends that Debrisoft is introduced admission was prevented, not only to current regime and if that benefit led to from infancy as it can be difficult to prevent the distress a hospital admission preservation of the epidermal barrier introduce new products later in life. would have caused her, but to prevent the by improving penetration of creams and Denyer states that Debrisoft will hopefully costs associated with admission. emollients. help in early detection of squamous cell carcinoma, as these tumours are often An interim report12 described the The intervention was offered to the concealed beneath crusts and debris. use of Debrisoft in the management of parents and was compared with their psoriasis and dry, scaly skin on two healthy current regime of gauze, flannel and volunteers. The basis of the study was to sponge. examine if it is possible to use Debrisoft in the management of skin conditions such Key results with Debrisoft were that as psoriasis and dry, scaly skin without in all 33 cases the condition was not adverse effect on the skin, and to establish made worse and in 31/33 cases no pain whether there was sufficient basis for a or discomfort was experienced. This more extensive study. was compared with 23/33 cases with their previous regime causing pain and Two volunteer subjects participated 22/33 cases where the condition was in this short study. Measurements were made worse due to increased itching and made using different measurement bleeding. In 31/33 cases dry skin came techniques including the Tissue Viability away more easily with the Debrisoft than Imager, Visioscan, Corneometer, with standard practice. There were many Tewameter, Mexameter, Colorimeter and positive comments received from parents, Skin Thermometer. Following baseline children and clinicians during the study. measurements Debrisoft was moistened and applied using a wiping motion to Key results with Debrisoft affected areas of skin. Twenty minutes after were that in all 33 cases the treatment a further set of measurements condition was not made were made. worse and in 31/33 cases In most cases the erythema no pain or discomfort was measurements were increased, which experienced may indicate an increased blood flow to the area. This is most likely due to In all parameters Debrisoft led to the massaging effect of Debrisoft. The an improved skin care regime when hydration figures were mostly increased. compared to their usual practice. Parents If the Debrisoft was causing damage to found it easier to apply creams and the skin the hydration figures would be emollients, and the affected area felt decreased. Initial TEWL results would smoother. It was pain and trauma free, and indicate that the monofilament pad does they would continue to use the product not impair the barrier function of the skin. as part of the daily management of their Figures 3,4 and 5. child’s skin condition. www.bdng.org.uk Dermatological Nursing, 2018, Vol 17, No 2 35 Product REVIEW In 2014, the first national guidance mainstay of treatment in these situations confidence.25 Debrisoft is outlined as a document was produced,14 outlining the are based on four main components; wound and skin debridement technique management of hyperkeratosis of the skin care, exercise, lymphatic drainage which requires minimal training and being lower limb. This was followed in 2015 and external compression and support. convenient and easy to use in patient’s by a UK consensus document.15 Both Greaves20 and Harding21 both report on home, GP surgery or an inpatient setting.5 documents acknowledge the role of the devastating psychological and social Debrisoft in the management of lower impact of these conditions and how the Debrisoft is outlined limb hyperkeratosis and how it can be management of the skin changes with as a wound and skin used by all health care professionals Debrisoft along with management of debridement technique working in hospital or community and by the other mainstay components led to patients and carers. Its ease of use may considerable improvements in quality of which requires minimal encourage patients to take an active role life, organisational cost savings. training in their care and undertake exfoliation of their own hyperkeratosis and dry skin.15 Whiteside and McIntyre22 describe Young26 describes the introduction of how they utilised the role of the band a skin care regimen in an elderly inpatient It is very important that hyperkeratosis 3 health care assistant in providing skin population. The elderly often suffer from is removed in a safe, atraumatic, way as care for lymphoedema patients in a dry skin when in hospital due to the any disruption of the skin integrity, for clinic setting under the direction of the aging process, frequent cleansing and the example by using forceps, increases the lymphoedema specialist.
Load more

Recommended publications
  • Review Skin Changes Are One of the Earliest Signs of Venous a R T I C L E Hypertension
    pp 11 - 19 ABSTRACT Review Skin changes are one of the earliest signs of venous A R T I C L E hypertension. Some of these changes such as venous eczema are common and easily identified whereas DERMATOLOGICAL other changes such as acroangiodermatitis are less common and more difficult to diagnose. Other vein MANIFESTATIONS OF VENOUS related and vascular disorders can also present with specific skin signs. Correct identification of these DISEASE: PART I skin changes can aid in making the right diagnosis and an appropriate plan of management. Given KUROSH PARSI, MBBS, MSc(Med), FACD, FACP the significant overlap between phlebology and Departments of Dermatology, St. Vincent’s Hospital and dermatology, it is essential for phlebologists to be Sydney Children’s Hospital familiar with skin manifestations of venous disease. Sydney Skin & Vein Clinic, This paper is the first installment in a series of 3 Bondi Junction, NSW, Australia and discusses the dermatological manifestations of venous insufficiency as well as other forms of vascular ectasias that may present in a similar Introduction fashion to venous incompetence. atients with venous disease often exhibit dermatological Pchanges. Sometimes these skin changes are the only clue to an appropriate list of differential diagnoses. Venous ulceration. Less common manifestations include pigmented insufficiency is the most common venous disease which purpuric dermatoses, and acroangiodermatitis. Superficial presents with a range of skin changes. Most people are thrombophlebitis (STP) can also occur in association with familiar with venous eczema, lipodermatosclerosis and venous incompetence but will be discussed in the second venous ulcers as manifestations of long-term venous instalment of this paper (Figure 2).
    [Show full text]
  • Progressive Widespread Warty Skin Growths
    DERMATOPATHOLOGY DIAGNOSIS Progressive Widespread Warty Skin Growths Patrick M. Kupiec, BS; Eric W. Hossler, MD Eligible for 1 MOC SA Credit From the ABD This Dermatopathology Diagnosis article in our print edition is eligible for 1 self-assessment credit for Maintenance of Certification from the American Board of Dermatology (ABD). After completing this activity, diplomates can visit the ABD website (http://www.abderm.org) to self-report the credits under the activity title “Cutis Dermatopathology Diagnosis.” You may report the credit after each activity is completed or after accumu- lating multiple credits. A 33-year-old man presented with progres- sive widespread warty skin growths that had been present copysince 6 years of age. Physical examination revealed numerous verrucous papules on the face and neck along with Figure 1. H&E, original magnification ×40. Figure 2. H&E, original magnification ×40. verrucous, tan-pink papules and plaques diffuselynot scattered on the trunk, arms, and legs. A biopsy of a lesion on the neck Dowas performed. H&E, original magnification ×200. The best diagnosisCUTIS is: a. condyloma acuminatum b. epidermodysplasia verruciformis c. herpesvirus infection d. molluscum contagiosum e. verruca vulgaris PLEASE TURN TO PAGE 99 FOR DERMATOPATHOLOGY DIAGNOSIS DISCUSSION Mr. Kupiec is from the State University of New York (SUNY) Upstate Medical University, Syracuse. Dr. Hossler is from the Departments of Dermatology and Pathology, Geisinger Medical Center, Danville, Pennsylvania. The authors report no conflict of interest. Correspondence: Patrick M. Kupiec, BS, 50 Presidential Plaza, Syracuse, NY 13202 ([email protected]). 82 CUTIS® WWW.CUTIS.COM Copyright Cutis 2017. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher.
    [Show full text]
  • Vulvar Disease: Overview of Diagnosis and Management for College Aged Women
    Vulvar Disease: Overview of Diagnosis and Management for College Aged Women Lynette J. Margesson MD FRCPC ACHA 2013 Annual Meeting, May 30, 2013 No Conflicts of interest Lynette Margesson MD Little evidence based treatment Most information is from small open trials and clinical experience. Most treatment discussed is “off-label” Why Do Vulvar Disease ? Not taught Not a priority Takes Time Still an area if taboo VULVAR CARE IS COMMONLY UNAVAILABLE For women this is devastating Results of Poor Vulvar Care Women : - suffer with undiagnosed symptoms - waste millions of dollars on anti-yeasts - hide and scratch - endure vulvar pain and dyspareunia - are desperate for help VULVA ! What is that? Down there? Vulvar Education Lets eliminate the “Down there” generation Use diagrams and handouts See www.issvd.org - patient education Recognize Normal Anatomy Normal vulvar anatomy Age Race Hormones determine structure - Size & shape - Pigmentation -Hair growth History A good,detailed,accurate history All previous treatment Response to treatment All medications, prescribed and over-the-counter TAKE TIME TO LISTEN Genital History in Women Limited by: embarrassment lack of knowledge social taboos Examination Tips Proper visualization - light + magnification Proper lighting – bright, but no glare Erythema can be normal Examine rest of skin, e.g. mouth, scalp and nails Many vulvar diseases scar, not just lichen sclerosus Special Anatomic Variations Sebaceous hyperplasia ectopic sebaceous glands Vulvar papillomatosis Pre-anesthesia – BIOPSY use a topical
    [Show full text]
  • Brown Papules and a Plaque on the Calf
    PHOTO CHALLENGE CLOSE ENCOUNTERS WITH THE ENVIRONMENT Brown Papules and a Plaque on the Calf Jin A. Kim, MD; Ji Hyun Lee, MD, PhD; Jun Young Lee, MD, PhD; Young Min Park, MD, PhD copy not Do A 61-year-old man presented with a cluster of asymptomatic brown papules and a plaque on the left calf of several years’ duration. The lesion consisted of multiple, dark brown, hyperkeratotic papules on a well-demarcated light brown flat plaque. The patient reported no increase in the size or number of lesions. He did not have a history of trauma or a per- sonal or family history of skin cancer. CUTIS What’s the diagnosis? a. agminated lentiginosis b. irritated seborrheic keratosis c. lentigo maligna melanoma d. speckled lentiginous nevus e. verruca plana From the Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul. The authors report no conflict of interest. Correspondence: Young Min Park, MD, PhD, Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-Gu, Seoul, South Korea ([email protected]). WWW.CUTIS.COM VOLUME 97, JUNE 2016 E17 Copyright Cutis 2016. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Photo Challenge Discussion The Diagnosis: Irritated Seborrheic Keratosis iopsies of one of the protruding papules and the The histology of SK shows monotonous basaloid underlying plaque were performed. The speci- tumor cells without atypia. It generally is com- Bmen from the papule showed hyperkeratosis, prised of focal acanthosis and papillomatosis with acanthosis, papillomatosis, and a flattened dermoepi- a sharp flat base.
    [Show full text]
  • Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients
    THERAPEUTICS FOR THE CLINICIAN Cutaneous Adverse Reaction to Infliximab: Report of Psoriasis Developing in 3 Patients Gregg A. Severs, DO; Tara H. Lawlor, DO; Stephen M. Purcell, DO; Donald J. Adler, DO; Robert Thompson, MD Infliximab is a chimeric immunoglobulin G1k nfliximab is a chimeric immunoglobulin monoclonal antibody against tumor necrosis fac- G1k monoclonal antibody (75% human and tor a (TNF-a), a proinflammatory cytokine that I 25% mouse origin) against tumor necrosis participates in both normal immune function and factor a (TNF-a). It neutralizes the biologic activity the pathogenesis of many autoimmune disorders. of TNF-a by directly binding to soluble and trans- Treatment with infliximab reduces the biologic membrane TNF-a molecules in the plasma and activities of TNF-a and thus is indicated in the on the surface of macrophages and T cells in dis- treatment of rheumatoid arthritis, Crohn disease, eased tissue. The binding destroys these TNF-a ankylosing spondylitis, psoriatic arthritis, plaque molecules via antibody-dependent cellular toxicity psoriasis, and ulcerative colitis. and complement-dependent cytotoxic mechanisms. To our knowledge, there have been 13 case Thus, infliximab decreases the actions of TNF-a, reports of new-onset psoriasis, psoriasiform der- which include induction of proinflammatory cyto- matitis, and palmoplantar pustular psoriasis that kines such as interleukins (IL) 1 and 6; enhancement developed during treatment with infliximab. We of leukocyte migration by increasing endothelial layer report 3 additional cases of biopsy-proven new- permeability and expression of adhesion molecules onset psoriasis that developed while the patients by endothelial cells and leukocytes; activation of underwent treatment with infliximab for inflamma- neutrophil and eosinophil functional activity; induc- tory bowel disease.
    [Show full text]
  • UC Davis Dermatology Online Journal
    UC Davis Dermatology Online Journal Title Multiple acantholytic dyskeratotic acanthomas in a liver-transplant recipient Permalink https://escholarship.org/uc/item/24v5t78z Journal Dermatology Online Journal, 25(4) Authors Kanitakis, Jean Gouillon, Laurie Jullien, Denis et al. Publication Date 2019 DOI 10.5070/D3254043575 License https://creativecommons.org/licenses/by-nc-nd/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Volume 25 Number 4| April 2019| Dermatology Online Journal || Case Presentation 25(4):6 Multiple acantholytic dyskeratotic acanthomas in a liver- transplant recipient Jean Kanitakis1,2, Laurie Gouillon1, Denis Jullien1, Emilie Ducroux1 Affiliations: 1Department of Dermatology, Edouard Herriot Hospital Group, Lyon, France, 2Department of Pathology, Centre Hospitalier Lyon Sud, Pierre Bénite, France Corresponding Author: Jean Kanitakis, Department of Dermatology, Edouard Herriot Hospital Group (Pavillion R), 69437 Lyon cedex 03, France, Tel: 33-472110301, Email: [email protected] (0.5mg/d) and prednisolone (5mg/d). He had Abstract recently developed end-stage renal disease and was Acantholytic dyskeratotic acanthoma is a rare variant undergoing hemodialysis. His post-transplant of epidermal acanthoma characterized pathologically medical history was significant for two melanomas by the presence of acantholysis and dyskeratosis. (one in situ on the abdomen diagnosed at the age of Few cases have been reported until now, one of them 61 years and a superficial spreading melanoma in a heart-transplant patient. We present here a new 2.4mm Breslow thickness of the dorsum of the foot case of this rare lesion that developed in a liver- diagnosed ten years later), a squamous cell transplant patient and review the salient features of this uncommon condition.
    [Show full text]
  • Skin and Wound Care in Lymphedema Patients: a Taxonomy, Primer, and Literature Review
    LITERATURE REVIEW Skin and Wound Care in Lymphedema Patients: A Taxonomy, Primer, and Literature Review Caroline E. Fife, MD, FACCWS; Wade Farrow, MD, FACCWS, CWSP; Adelaide A. Hebert, MD, FACCWS; Nathan C. Armer, MEd; Bob R. Stewart, EdD; Janice N. Cormier, MD, MPH, FACS; and Jane M. Armer, PhD, RN, FAAN, CLT INTRODUCTION ABSTRACT As part of a systematic review to evaluate the level of evidence of BACKGROUND: Lymphedema is a condition of localized contemporary peer-reviewed lymphedema literature in support protein-rich swelling from damaged or malfunctioning of the second edition of a Best Practices document, publications lymphatics. Because the immune system is compromised, on skin care and wounds were retrieved, summarized, and eval- there is a high risk of infection. Infection in patients with uated by teams of investigators and clinical experts. A joint pro- lymphedema may present in a variety of ways. ject of the American Lymphedema Framework Project and the OBJECTIVE: The goals of this review were to standardize the International Lymphoedema Framework, the objectives are to terminology of skin breakdown in the context of lymphedema, provide evidence of the best practices in lymphedema care and synthesize the available information to create best practice management and to increase lymphedema awareness in the recommendations in support of the American Lymphedema United States and worldwide. Framework Project update to its Best Practices document, and create recommendations for further research. BACKGROUND DATA SOURCES: Publications on skin care and wounds were Lymphedema is a disfiguring condition that can result in signifi- retrieved, summarized, and evaluated by a team of investigators cant impairment in quality of life and function.1 The skin cons- and clinical experts.
    [Show full text]
  • Cutaneous Manifestations in Pancreatic Diseases—A Review
    Journal of Clinical Medicine Review Cutaneous Manifestations in Pancreatic Diseases—A Review 1, 2,3, , 1,2 2,3 Raluca Miulescu y, Daniel Vasile Balaban * y , Florica Sandru and Mariana Jinga 1 Dermatology Department, Elias University Emergency Hospital, 011461 Bucharest, Romania; [email protected] (R.M.); fl[email protected] (F.S.) 2 Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, 030167 Bucharest, Romania; [email protected] 3 Gastroenterology Department, “Dr. Carol Davila” Central Military Emergency University Hospital, 010825 Bucharest, Romania * Correspondence: [email protected] These authors contributed equally. y Received: 13 July 2020; Accepted: 7 August 2020; Published: 12 August 2020 Abstract: Pancreatic pathology, comprising acute and chronic pancreatitis, autoimmune pancreatitis and pancreatic neoplasms, primarily presents with gastrointestinal symptoms and signs; however, it is well recognized that it can also associate a wide range of extra-digestive features. Among these systemic manifestations, cutaneous involvement plays an important role both as a diagnostic clue for the pancreatic disease itself and serving as a prognostic factor for the severity of the condition. Recognition of these cutaneous signs is, however, far from being satisfactory, all the more as some of them are relatively rare. In the current review, we discuss skin involvement in pancreatic diseases, referring to pancreatic panniculitis, cutaneous hemorrhagic manifestations, skin metastasis, acanthosis nigricans, livedo reticularis, necrolytic migratory erythema and cutaneous fistula. We highlight the clinical characteristics, treatment and prognostic value of these lesions. Better awareness among medical specialties other than dermatology is needed for detection of the skin clues associated with pancreatic pathology. Keywords: acute pancreatitis; chronic pancreatitis; pancreatic cancer; cutaneous; pancreatic panniculitis; acanthosis nigricans 1.
    [Show full text]
  • Assessment, Diagnosis and Management of Leg Ulcers
    Assessment, diagnosis and management of leg ulcers Sarah Gardner, Clinical lead, Tissue viability service What are the challenges of leg ulcer management? How do you feel when a patient is referred with a leg ulcer? How do you think your patient feels about their leg ulcer? Aim of the session To develop a better understanding of the factors that contribute to the development of leg ulceration and how the application of proven treatments can improve clinical outcomes Objectives - } To gain a better understanding of the anatomy & Physiology of the vascular system } To understand the function of the veins and how venous incompetence can lead to skin breakdown } Be able to carry out a full holistic leg ulcer assessment in order to correctly diagnose the aetiology. } On diagnosis, be able to put an appropriate plan of care in place in order to support timely wound healing } Be able to differentiate between ‘normal’ and ‘abnormal’ ulceration and recognise when referral is necessary. Leg ulcer training? Why bother? } Hopefully you are here because you want to be } We have variable healing rates } LU assessment not always ‘holistic’ } Bandaging ‘challenges’ } Wounds that are constantly colonised and inflammatory } Wounds that are not progressing aren't always referred on in a timely way } Pain is difficult to manage } Co morbidities are sometimes seen in isolation to the wound Exposed tendon Chronic ulceration … what is effective leg ulcer management? Arterial or venous??? Skin condition or leg ulceration? Multiple wound types… Stubborn ulcers over the malleoli… Severe local infection… what do we do? When does trauma become leg ulceration? The tipping point….
    [Show full text]
  • Acantholytic Seborrheic Keratosis J Wang, B Wang, J Shehan, D Sarma
    The Internet Journal of Dermatology ISPUB.COM Volume 6 Number 2 Acantholytic Seborrheic Keratosis J Wang, B Wang, J Shehan, D Sarma Citation J Wang, B Wang, J Shehan, D Sarma. Acantholytic Seborrheic Keratosis. The Internet Journal of Dermatology. 2007 Volume 6 Number 2. Abstract We are reporting a rare case of an acantholytic seborrheic keratosis and briefly reviewing the relevant literature. INTRODUCTION Figure 1 Seborrheic keratoses are one of the most common benign Figure 1: Seborrheic keratosis, low magnification. cutaneous tumors in older population. They can occur on any part of the body; however, the back and chest are common locations. The appearance of seborrheic keratoses can vary widely. They may be light tan to brown or black. The most common texture is rough, with a bumpy, grainy surface that crumbles easily. Typically, they appear as dark ‘stuck-on' lesion on the skin surface. Seborrheic keratosis with acantholysis is a rare variant. Acantholysis represents an epidermal cell separation as a result of breakdown of the intracellular connections, leading to the loss of cohesion between keratinocytes. CASE REPORT A 60-year-old female presented with ‘a mole' on her back that had recently become somewhat irritated. She had had a few similar lesions removed previously, which were all Figure 2 benign. Examination of her mid back revealed a 6-mm Figure 2: Acantholytic seborrheic keratosis, higher keratotic plaque with darker black areas at the edges. The magnification. clinical diagnosis was “inflamed seborrheic keratosis”. On microscopic examination of the excised lesion, the tumor showed the typical histological features of seborrheic keratosis including hyperkeratosis, acanthosis composed of dark basaloid cells, and papillomatosis, and keratinous horn cysts.
    [Show full text]
  • Acantholytic Dyskeratosis Occurring Within an Epidermal Nevus
    Acantholytic Dyskeratosis Occurring Within an Epidermal Nevus Shilpi Khetarpal, MD; Michelle Tarbox, MD; Ralph J. Tuthill, MD; Allison Vidimos, MD, RPh Practice Points Epidermal nevi are congenital epidermal malformations that follow the lines of Blaschko and present between birth and adolescence. There are several histologic subtypes. Acantholytic dyskeratosis is a histologic pattern with acanthosis, papillomatosis, and hyperkeratosis con- taining acantholytic and dyskeratotic keratinocytes in the epidermis. These findings are distinctive but not pathognomonic for Darier disease because they occur in other conditions such as Grover disease, warty dyskeratoma, Starink hamartoma, or acantholytic dyskeratotic epidermal nevi. A 25-year-old woman presented with a large area Blaschko on the left side of the body that had been of flesh-colored verrucous CUTISplaques following the present since 6 months of age. The plaques had been lines of Blaschko on the left side of the body that stable and grew proportionately with the patient’s had been present since 6 months of age. The body until she reached 20 years of age when they plaques had been stable and grew proportion- began to thicken and enlarge. Her medical and family ately with the patient’s body until she reached history was unremarkable. The patient reported mild 20 years of age when they began to thicken and pruritus but no pain. Prior therapies included ammo- enlarge. Her medical and family history was unre- nium lactate lotion 12% without benefit. markable.Do A shave biopsy revealedNot a papilloma- PhysicalCopy examination revealed numerous flesh- tous epidermis with 3 discrete foci of acantholytic colored verrucous papules coalescing into linear dyskeratosis, with corps ronds and grains that hypertrophic plaques along with several 2- to 3-mm were similar to the histologic findings of Darier solitary papules involving the left lateral leg, abdo- disease (DD).
    [Show full text]
  • Confluent and Reticulated Papillomatosis
    Journal of the American Osteopathic College of Dermatology Journal of the American Osteopathic College of Dermatology 2009-2010 AOCD Officers President: Marc I. Epstein, D.O., FAOCD President-Elect: Leslie Kramer, D.O., FAOCD First Vice-President: Bradley P. Glick, D.O., FAOCD Second Vice-President: James B. Towry, D.O., FAOCD Third Vice-President: Karen E. Neubauer, D.O., FAOCD Secretary - Treasurer: Jere J. Mammino, D.O., FAOCD Immediate Past-President: Donald K. Tillman, Jr., D.O., FAOCD Trustees: David L. Grice, D.O., FAOCD Mark A. Kuriata, D.O., FAOCD Rick Lin, D.O., FAOCD Editors Suzanne Rozenberg, D.O., FAOCD Jay S. Gottlieb, DO Andrew Racette, D.O., FAOCD Jon Keeling, DO Celeste Angel, D.O., FAOCD Andrew Racette, DO Executive Director: Rebecca Mansfield Editorial Review Board Kevin Belasco, DO Sponsors: Rich Bernert, M.D. Global Pathology Laboratory JAOCD Iqbal Bukhari, MD Medicis Founding Sponsor Ryan Carlson, DO JAOCD Founding Sponsor Igor Chaplik, DO Galderma Michael Conroy, M.D. Ranbaxy Brad Glick, DO, FAOCD Melinda Greenfield, DO Andrew J Hanly, MD JAOCD David Horowitz, DO, FAOCD Founding Sponsor Matt Leavitt, DO, FAOCD AOCD • 1501 E. Illinois • Kirksville, MO 63501 Mark Lebwohl, MD 800-449-2623 • FAX: 660-627-2623 www.aocd.org Rick Lin, DO Megan Machuzak, D.O. COPYRIGHT AND PERMISSION: written permission must be obtained from the Journal of the American Osteopathic College of Dermatology Jere Mammino, DO, FAOCD for copying or reprinting text of more than half page, tables or figures. John Minni, DO Permissions are normally granted contingent upon similar permission from the author(s), inclusion of acknowledgement of the original source, Navid Nami, DO and a payment of $15 per page, table or figure of reproduced material.
    [Show full text]